Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Seastar Medical Holding's Business Segments
Seastar Medical Holding's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of FY
Reportable Segments
2
Largest Segment
Quelimmune
Total Revenue
$ 1
Regions Reported
-
Revenue Share by Reportable Segment - FY
- Quelimmune0%
- Single Reportable Segment0%
Revenue by Reportable Segment - FY
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Quelimmune | $ 3 | - |
| Single Reportable Segment | $ 1 | - |
Revenue by Product & Service Category - FY
- Quelimmune0%
Revenue by Product & Service Category - FY
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Quelimmune | $ 2 | - |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Annual Results
Revenue Share by Reportable Segment - FY
- Quelimmune0%
- Single Reportable Segment0%
Revenue by Reportable Segment - FY
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Quelimmune | $ 3 | - |
| Single Reportable Segment | $ 1 | - |
Description of Seastar Medical Holding
Seastar Medical Holding Corporation is a multinational healthcare conglomerate that operates globally in the field of medical technology and healthcare solutions. The company was founded in 1990 and has since grown to become one of the leading players in the healthcare industry.
The primary focus of Seastar Medical Holding Corporation is to develop and manufacture innovative medical devices, equipment, and solutions that enhance patient care and improve healthcare outcomes. The company has a wide portfolio of products designed for various medical specialties such as cardiology, radiology, neurology, orthopedics, and general surgery.
Seastar Medical Holding Corporation has a strong research and development department that constantly works towards developing cutting-edge technologies and solutions to tackle the evolving needs of the healthcare industry. The company invests heavily in research and innovation to ensure its products are at the forefront of medical advancements.
The company has a vast network of manufacturing facilities and distribution centers located around the world, enabling it to provide its products and services to healthcare providers in over 100 countries. Seastar Medical Holding Corporation has established itself as a trusted provider of medical equipment and solutions, catering to both public and private healthcare institutions.
In addition to its manufacturing and distribution capabilities, Seastar Medical Holding Corporation also offers a range of supporting services such as installation, maintenance, and training to ensure its products are properly utilized and maintained by healthcare professionals. The company has a dedicated team of experts who provide technical support and assistance to healthcare providers to maximize the benefits of using Seastar's products.
Seastar Medical Holding Corporation is committed to quality and safety in the healthcare industry. The company strictly adheres to international standards and regulations and has obtained various certifications to ensure its products meet the highest quality standards. Additionally, the company has implemented robust quality control measures throughout its manufacturing processes to ensure the reliability and effectiveness of its products.
The company's corporate culture is centered around innovation, collaboration, and customer-centricity. Seastar Medical Holding Corporation encourages its employees to think outside the box and contribute towards advancing healthcare solutions. The company fosters a collaborative work environment that encourages cross-functional teams to work together towards achieving common goals.
Seastar Medical Holding Corporation is also actively involved in corporate social responsibility initiatives. The company supports various charitable causes related to healthcare and invests in programs aimed at improving access to healthcare in underserved communities. The company also promotes sustainability by implementing environmentally friendly practices and reducing its carbon footprint.
Overall, Seastar Medical Holding Corporation is a global leader in the healthcare industry, known for its innovative medical devices, commitment to quality, and dedication to improving patient care. With its extensive network, cutting-edge technology, and customer-centric approach, the company continues to make significant contributions to the advancement of healthcare worldwide.
The primary focus of Seastar Medical Holding Corporation is to develop and manufacture innovative medical devices, equipment, and solutions that enhance patient care and improve healthcare outcomes. The company has a wide portfolio of products designed for various medical specialties such as cardiology, radiology, neurology, orthopedics, and general surgery.
Seastar Medical Holding Corporation has a strong research and development department that constantly works towards developing cutting-edge technologies and solutions to tackle the evolving needs of the healthcare industry. The company invests heavily in research and innovation to ensure its products are at the forefront of medical advancements.
The company has a vast network of manufacturing facilities and distribution centers located around the world, enabling it to provide its products and services to healthcare providers in over 100 countries. Seastar Medical Holding Corporation has established itself as a trusted provider of medical equipment and solutions, catering to both public and private healthcare institutions.
In addition to its manufacturing and distribution capabilities, Seastar Medical Holding Corporation also offers a range of supporting services such as installation, maintenance, and training to ensure its products are properly utilized and maintained by healthcare professionals. The company has a dedicated team of experts who provide technical support and assistance to healthcare providers to maximize the benefits of using Seastar's products.
Seastar Medical Holding Corporation is committed to quality and safety in the healthcare industry. The company strictly adheres to international standards and regulations and has obtained various certifications to ensure its products meet the highest quality standards. Additionally, the company has implemented robust quality control measures throughout its manufacturing processes to ensure the reliability and effectiveness of its products.
The company's corporate culture is centered around innovation, collaboration, and customer-centricity. Seastar Medical Holding Corporation encourages its employees to think outside the box and contribute towards advancing healthcare solutions. The company fosters a collaborative work environment that encourages cross-functional teams to work together towards achieving common goals.
Seastar Medical Holding Corporation is also actively involved in corporate social responsibility initiatives. The company supports various charitable causes related to healthcare and invests in programs aimed at improving access to healthcare in underserved communities. The company also promotes sustainability by implementing environmentally friendly practices and reducing its carbon footprint.
Overall, Seastar Medical Holding Corporation is a global leader in the healthcare industry, known for its innovative medical devices, commitment to quality, and dedication to improving patient care. With its extensive network, cutting-edge technology, and customer-centric approach, the company continues to make significant contributions to the advancement of healthcare worldwide.
Seastar Medical Holdings Corporation is a biotechnology company focused on developing innovative therapeutic solutions for patients requiring organ support due to acute kidney injury (AKI) and other serious health conditions. The company primarily concentrates on technologies that facilitate better patient outcomes in critical care settings.
Segments
1. Therapeutics for Organ Support:
This segment encompasses the development and commercialization of novel medical therapies that provide renal replacement therapy (RRT) designed to alleviate the burdens associated with traditional dialysis. Seastar aims to create more efficient and less invasive options to manage acute kidney injuries and improve overall patient survival rates.
2. Medical Devices:
Seastar develops proprietary medical devices that integrate advanced technologies to support organ function. These devices are intended for use in hospitals and clinics, providing alternative solutions to existing renal therapies.
3. Clinical Trials and Research:
Engaging in extensive clinical research and trials is a core segment for Seastar, driving the evidence base for their products and refining their therapeutic offerings. This segment focuses on gathering data that demonstrates the safety, efficacy, and improved outcomes of their therapies.
Products
1. Sapphire® Technology:
The flagship product of Seastar Medical is its personalized renal replacement therapy device, the Sapphire® system. This platform aims to improve outcomes for patients with AKI by using a novel approach to filtration and treatment modalities. The Sapphire® system is designed to minimize complications, shorten recovery times, and offer better quality of life for patients suffering from acute kidney conditions.
2. Disease Management Solutions:
Seastars products include a suite of solutions designed to address various aspects of managing acute kidney injury. These products encompass both pharmacological and non-pharmacological approaches aimed at improving kidney health and function during critical illness.
3. Patient Monitoring Devices:
Seastar is involved in developing monitoring devices that provide real-time data on kidney function in critically ill patients. These devices aid medical professionals in making timely decisions regarding treatment adjustments and interventional strategies.
Services
1. Patient Education and Support:
Seastar provides comprehensive educational resources and support services for healthcare providers and patients. This service aims to ensure effective use of their products and enhance understanding of acute kidney injury management.
2. Clinical Partnerships:
Seastar actively collaborates with healthcare institutions and research organizations to advance kidney health solutions. These partnerships are focused on conducting clinical trials, sharing knowledge, and developing comprehensive treatment protocols that incorporate Seastars innovative therapies.
3. Technical Support and Training:
Post-product launch, Seastar offers technical support and training for medical personnel to ensure the optimal use of their devices and therapies. This service encompasses training sessions, manuals, and continued assistance, ensuring that healthcare professionals are well-equipped to use the companys products effectively.
Conclusion
Overall, Seastar Medical Holdings Corporation is at the forefront of developing advanced therapeutic technologies aimed at enhancing organ support and managing acute kidney injury. Their focus on innovative products, valuable services, and strong clinical partnerships underscores their commitment to improving patient care and outcomes in critical situations.
Segments
1. Therapeutics for Organ Support:
This segment encompasses the development and commercialization of novel medical therapies that provide renal replacement therapy (RRT) designed to alleviate the burdens associated with traditional dialysis. Seastar aims to create more efficient and less invasive options to manage acute kidney injuries and improve overall patient survival rates.
2. Medical Devices:
Seastar develops proprietary medical devices that integrate advanced technologies to support organ function. These devices are intended for use in hospitals and clinics, providing alternative solutions to existing renal therapies.
3. Clinical Trials and Research:
Engaging in extensive clinical research and trials is a core segment for Seastar, driving the evidence base for their products and refining their therapeutic offerings. This segment focuses on gathering data that demonstrates the safety, efficacy, and improved outcomes of their therapies.
Products
1. Sapphire® Technology:
The flagship product of Seastar Medical is its personalized renal replacement therapy device, the Sapphire® system. This platform aims to improve outcomes for patients with AKI by using a novel approach to filtration and treatment modalities. The Sapphire® system is designed to minimize complications, shorten recovery times, and offer better quality of life for patients suffering from acute kidney conditions.
2. Disease Management Solutions:
Seastars products include a suite of solutions designed to address various aspects of managing acute kidney injury. These products encompass both pharmacological and non-pharmacological approaches aimed at improving kidney health and function during critical illness.
3. Patient Monitoring Devices:
Seastar is involved in developing monitoring devices that provide real-time data on kidney function in critically ill patients. These devices aid medical professionals in making timely decisions regarding treatment adjustments and interventional strategies.
Services
1. Patient Education and Support:
Seastar provides comprehensive educational resources and support services for healthcare providers and patients. This service aims to ensure effective use of their products and enhance understanding of acute kidney injury management.
2. Clinical Partnerships:
Seastar actively collaborates with healthcare institutions and research organizations to advance kidney health solutions. These partnerships are focused on conducting clinical trials, sharing knowledge, and developing comprehensive treatment protocols that incorporate Seastars innovative therapies.
3. Technical Support and Training:
Post-product launch, Seastar offers technical support and training for medical personnel to ensure the optimal use of their devices and therapies. This service encompasses training sessions, manuals, and continued assistance, ensuring that healthcare professionals are well-equipped to use the companys products effectively.
Conclusion
Overall, Seastar Medical Holdings Corporation is at the forefront of developing advanced therapeutic technologies aimed at enhancing organ support and managing acute kidney injury. Their focus on innovative products, valuable services, and strong clinical partnerships underscores their commitment to improving patient care and outcomes in critical situations.